About us

TheSocialMedwork is a social enterprise helping people everywhere access the latest medicines more quickly in countries where those medicines are not available. We are a registered, independent medicines intermediary sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. The only organisation in the world doing this today, we have helped 11,000 patients so far and strive to give everyone in the world access to the best new medicines. 

Sjaak Vink, talking about putting patients first on Australian news. 

TheSocialMedwork was founded by Sjaak Vink, co-founder of myTomorrows and experienced healthcare innovator, together with James Heywood, influential speaker, scientist, big-data expert and co-founder of Patients Like Me; Bernard Muller, founder of Project MinE and Treeway and himself an ALS/MND patient, and Katrin Schepp, Attorney-at-Law.

"I was representing a group of European patients who were lobbying for faster approval of a breakthrough cancer medicine which had already been approved by the US. By the time it was approved in Europe they had all passed away. It was then that I knew these fragmented, arbitrary, and unnecessary drug delays were something that needed action right now, not tomorrow."

Sjaak Vink, CEO and Founder.


At the heart of our approach is true patient-centricity. This is more than putting patients first – we believe in empowering people to have every available option ready when they consult a healthcare professional. Nobody should suffer from the inability to access the latest scientific and medical breakthroughs because of their location.

We are a registered medicines intermediary with the Ministry of Health of The Netherlands, Hague, registration: 6730 BEM.

We strive for a world where everybody, no matter who they are or where they live, has equal and fair access to the latest and best healthcare. This is because we firmly believe that health enables personal freedom and opportunity.

Do you agree? Add your voice to our Facebook community.